Tag
Novartis India Limited
10 articles
Novartis India’s first-quarter results reflect a strong start to fiscal year 2027, with net profit rising 28% year-over-year, driven by increased revenue from operations. This positive performance occurs amidst a significant ownership transition, as WaveRise Investments and ChrysCapital move to acquire a 70.68% stake from Novartis AG. While a mandatory open offer for the remaining 26% stake was launched, it has received a surprisingly minimal response from public shareholders, indicating limited interest in selling at the offered price of ₹860.64 per share. The impending change in control and the muted open offer response suggest a period of transition for Novartis India, with investors likely monitoring the acquirers' strategic direction and integration plans.
Dr. Reddy's Terminates Novartis India Brand Agreement
Dr. Reddy's Laboratories terminated its distribution agreement with Novartis India Limited effective immediately.
The termination was triggered by a change in the controlling shareholding of Novartis
Novartis AG Sells Entire 70.68% Stake
Novartis AG sold its entire 70.68% holding (1.74 crore shares) in Novartis India Limited on July 29, 2026.
The sale was executed off-market pursuant to a purchase agreement dated February 19, 2026.
No
Novartis AG Sells Entire 70.68% Stake in Novartis India
Novartis AG sold its entire 70.68% stake, comprising 1.74 crore equity shares, in Novartis India Limited.
The off-market transaction was valued at approximately ₹1,376.89 crore and executed on July 29
Novartis AG Reclassified to Public Shareholder
Novartis AG completes sale of 70.68% stake in Novartis India to ChrysCapital entities, ceasing to be promoter.
ChrysCapital's WaveRise and Fund X acquire control, triggering a mandatory 26% open offer
WaveRise ChrysCapital Novartis India Open Offer Completion
Axis Capital submits post-offer ad for completed open offer by WaveRise Investments and ChrysCapital for 26% stake in Novartis India.
Open offer acquired 64.19 lakh shares at ₹5,524.97 crore total val
Novartis India Open Offer Receives Minimal Tender Response
Axis Capital discloses tender update for Novartis India open offer by WaveRise, ChrysCapital, and Two Infinity.
Zero equity shares tendered in demat form and only 10 physical shares received as of Jun
Novartis India Open Offer Receives Minimal Share Tender
• Axis Capital discloses tender status for Novartis India's 26% open offer by WaveRise and ChrysCapital.
• Zero equity shares tendered in dematerialized form as of June 18, 2026.
• Only 10 physical sh
Novartis India Open Offer Receives Zero Shares Tendered
Axis Capital discloses zero equity shares were tendered on June 17, 2026, in the open offer for Novartis India.
The open offer is for acquiring up to 26% of Novartis India's voting share capital from
Novartis India Open Offer Receives Zero Shares
Axis Capital discloses zero equity shares tendered on first day of Novartis India open offer.
No shares were received in both dematerialized and physical form by the offer's escrow and registrar.
The
Novartis India 26% Open Offer at ₹860.64/Share
Acquirers announce mandatory open offer for 26% of Novartis India shares at ₹860.64 per share.
Independent Directors Committee recommends the offer as fair per SEBI pricing regulations.
Tendering peri